百奧泰(688177.SH)2020年預虧4.53億元-5.44億元
格隆匯1月29日丨百奧泰(688177.SH)披露2020年度業績預虧公吿,預計2020年度實現歸屬於母公司所有者的淨利潤-4.53億元到-5.44億元,相比上期減少虧損4.79億元到5.69億元;預計2020年度歸屬於母公司所有者扣除非經常性損益後的淨利潤-4.90億元到-5.88億元,相比上期減少虧損0.97億元到1.95億元。
業績變化的主要原因系:(一)主營業務影響。公司產品格樂立2020年開始上市銷售,預計銷售收入增加1.70億元至2.03億元。(二)非經營性損益的影響。由於上期存在股權激勵產生費用3.52億元,報吿期無此費用,一定程度上減少虧損金額。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.